• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Galectin Therap released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.128 (forecast USD -0.11)
04:00
Galectin Therap released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.4015
04:00
Nov10
Galectin Therapeutics Reports Positive Results for Belapectin in MASH Liver Disease 2b Phase NAVIGATE Trial
12:57
Aug15
Galectin Therap released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.2714
03:00
Galectin Therap released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.12 (forecast USD -0.16)
03:00
Jul9
Galectin Therapeutics Inc. Receives $10 Million Credit Line
11:56

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.223 M, EPS -0.128

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.584 M, EPS -0.1195

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.605 M, EPS -0.1519

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
458.854
+225.43%
+309.010
GURE
9.830
+107.38%
+5.090
WHLR
5.439
+67.85%
+2.199
TGL
11.160
+65.14%
+4.402
TWNP
1.785
+56.58%
+0.645
TDIC
0.4199
+49.54%
+0.139
IRBT
4.290
+41.58%
+1.255
GFR.RT
1.180
+38.82%
+0.330
PRAX
259.700
+36.71%
+69.730
CLIK
7.700
+35.09%
+2.000
View More